Guidelines for Accurate and Transparent Health Estimates Reporting
The Gather statement
Bibliographic Data
Measurements of health indicators are rarely available for every population and period of interest, and available data may not be comparable. The Guidelines for Accurate and Transparent Health Estimates Reporting (GATHER) define best reporting practices for studies that calculate health estimates for multiple populations (in time or space) using multiple information sources. Health estimates that fall within the scope of GATHER include all quantitative population-level estimates (including global, regional, national, or subnational estimates) of health indicators, including indicators of health status, incidence and prevalence of diseases, injuries, and disability and functioning; and indicators of health determinants, including health behaviours and health exposures. GATHER comprises a checklist of 18 items that are essential for best reporting practice. A more detailed explanation and elaboration document, describing the interpretation and rationale of each reporting item along with examples of good reporting, is available on the GATHER website.
Checklist · Environmental health · Health indicator · Population · Population health · Scope (computer science) · Statistics · Under-reporting · Computer Science · Global Health Care Issues · Health Systems, Economic Evaluations, Quality of Life · Healthcare cost, quality, practices · Mathematics · Medicine · Psychology
Mapping the landscape of congenital anomaly registries worldwide
Reporting guidelines in global health research
Reporting of health estimates prior to Gather
Impact of the 2008 economic crisis on the burden of hepatitis B and C diseases in Southern European countries
Authorship Not Taught and Not Caught in Undergraduate Research Experiences at a Research University
Global, Regional, National, and Subnational Big Data to Inform Health Equity Research
Life expectancy, healthy life expectancy, and burden of disease in older people in the Americas, 1990–2019
Mortality, morbidity, and risk factors in China and its provinces, 1990–2017
Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015
Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050
Global, regional, and national burden of mortality and Dalys attributable to high body mass index from 1990 to 2021 with projections to 2036
The global, regional, and National burden of parkinson’s disease in 204 countries and territories, 1990–2021
Burden and changes in HIV/Aids morbidity and mortality in Southern Africa Development Community Countries, 1990–2017
Epidemiological trend in diabetic kidney disease (DKD) burden in China from 1990 to 2021, and projections for 2041
Global, regional, and national trends in maternal hemorrhage, 1992–2021
Global, regional, and national burden of infective endocarditis from 2010 to 2021 and predictions for the next five years
Global, regional, and national burden of blindness and vision loss attributable to smoking from 1990 to 2021, and forecasts to 2030
Global prevalence and burden of depressive and anxiety disorders in 204 countries and territories in 2020 due to the Covid-19 pandemic
Global Health
Global, regional, and national burden of neurological disorders, 1990–2016
The State of US Health, 1990-2016
Unintended pregnancy and abortion by income, region, and the legal status of abortion
Gender equality in science, medicine, and global health
Global, regional, and national disability-adjusted life-years (Dalys) for 359 diseases and injuries and healthy life expectancy (Hale) for 195 countries and territories, 1990–2017
Global, regional, and national prevalence estimates of physical or sexual, or both, intimate partner violence against women in 2018
Global, regional, and national levels of maternal mortality, 1990–2015
The Global Burden of Disease Study at 30 years
Burden of disease from inadequate water, sanitation and hygiene for selected adverse health outcomes
The WHO estimates of excess mortality associated with the Covid-19 pandemic
Estimates of global seasonal influenza-associated respiratory mortality
Global, regional, and national age-sex-specific mortality and life expectancy, 1950–2017
Global, regional, and national deaths, prevalence, disability-adjusted life years, and years lived with disability for chronic obstructive pulmonary disease and asthma, 1990–2015
Global, regional, and national progress towards Sustainable Development Goal 3.2 for neonatal and child health
Measuring progress and projecting attainment on the basis of past trends of the health-related Sustainable Development Goals in 188 countries
Epidemiology of injecting drug use, prevalence of injecting-related harm, and exposure to behavioural and environmental risks among people who inject drugs
Physical Activity and Sports—Real Health Benefits
Global, regional, national, and selected subnational levels of stillbirths, neonatal, infant, and under-5 mortality, 1980–2015
Global age-sex-specific fertility, mortality, healthy life expectancy (Hale), and population estimates in 204 countries and territories, 1950–2019
Burden of disease scenarios for 204 countries and territories, 2022–2050
Changes in the global burden of depression from 1990 to 2017
Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016
Global burden of bacterial antimicrobial resistance 1990–2021
Worldwide Prevalence and Disability From Mental Disorders Across Childhood and Adolescence
Global, regional, and national estimates of pneumonia morbidity and mortality in children younger than 5 years between 2000 and 2015
Causes of blindness and vision impairment in 2020 and trends over 30 years, and prevalence of avoidable blindness in relation to Vision 2020
The global burden of disease attributable to alcohol and drug use in 195 countries and territories, 1990–2016
Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990–2021
National, regional, and global estimates of preterm birth in 2020, with trends from 2010
Global fertility in 204 countries and territories, 1950–2021, with forecasts to 2100
Global, regional, and national burden of suicide mortality 1990 to 2016
Smoking prevalence and attributable disease burden in 195 countries and territories, 1990–2015
Global, regional, and national burdens of ischemic heart disease and stroke attributable to exposure to long working hours for 194 countries, 2000–2016
Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050
Healthcare Access and Quality Index based on mortality from causes amenable to personal health care in 195 countries and territories, 1990–2015
Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017
Spatial, temporal, and demographic patterns in prevalence of smoking tobacco use and attributable disease burden in 204 countries and territories, 1990–2019
Prevalence and attributable health burden of chronic respiratory diseases, 1990–2017
Alcohol use and burden for 195 countries and territories, 1990–2016
Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990–2021
National, regional, and global trends in insufficient physical activity among adults from 2000 to 2022
Global, regional, and country-level coverage of interventions to prevent and manage HIV and hepatitis C among people who inject drugs
Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990–2017
Suicide trends in the early months of the Covid-19 pandemic
Global, Regional, and National Levels and Trends in Burden of Oral Conditions from 1990 to 2017
Association of Opioid Agonist Treatment With All-Cause Mortality and Specific Causes of Death Among People With Opioid Dependence
Global, regional, and national disability-adjusted life-years (Dalys) for 315 diseases and injuries and healthy life expectancy (Hale), 1990–2015
Global, regional, and national burden of chronic kidney disease, 1990–2017
Pandemic preparedness and Covid-19
Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990–2016
Measuring universal health coverage based on an index of effective coverage of health services in 204 countries and territories, 1990–2019
Measuring performance on the Healthcare Access and Quality Index for 195 countries and territories and selected subnational locations
Estimating excess mortality due to the Covid-19 pandemic
Estimates of the global, regional, and national morbidity, mortality, and aetiologies of diarrhoea in 195 countries
Measuring progress from 1990 to 2017 and projecting attainment to 2030 of the health-related Sustainable Development Goals for 195 countries and territories
Global age-sex-specific mortality, life expectancy, and population estimates in 204 countries and territories and 811 subnational locations, 1950–2021, and the impact of the Covid-19 pandemic
Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (Dalys), and healthy life expectancy (Hale) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990–2021
Global, regional, and national under-5 mortality, adult mortality, age-specific mortality, and life expectancy, 1970–2016
Measuring the health-related Sustainable Development Goals in 188 countries
Population-level risks of alcohol consumption by amount, geography, age, sex, and year
Estimates of the global, regional, and national morbidity, mortality, and aetiologies of lower respiratory infections in 195 countries, 1990–2016
Hearing loss prevalence and years lived with disability, 1990–2019
IDF Diabetes Atlas
Global prevalence of injecting drug use and sociodemographic characteristics and prevalence of HIV, HBV, and HCV in people who inject drugs
Global, Regional, and National Prevalence, Incidence, and Disability-Adjusted Life Years for Oral Conditions for 195 Countries, 1990–2015
Global, regional, and national burden of stroke, 1990–2016
Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990–2015
Global, regional, and national sepsis incidence and mortality, 1990–2017
Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990–2015
Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life Years for 29 Cancer Groups From 2010 to 2019
Fertility, mortality, migration, and population scenarios for 195 countries and territories from 2017 to 2100
Burden of disease in Brazil, 1990–2016
Global, regional, and national disability-adjusted life-years (Dalys) for 333 diseases and injuries and healthy life expectancy (Hale) for 195 countries and territories, 1990–2016
Global burden of 87 risk factors in 204 countries and territories, 1990–2019
Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017
Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019
Global, regional, and national burden of maternal hypertensive disorder
Trends analysis of the global burden of hypertensive heart disease from 1990 to 2021
Global trends in the burden of ischemic heart disease based on the global burden of disease study 2021
Global, regional, and national epidemiology of cervical cancer in elderly women from 1990 to 2021 and its prediction to 2035
Global, regional, and national burden of cardiovascular diseases attributable to metabolic risks across all age groups from 1990 to 2021
The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement
Consort 2010 Statement
The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement
Consolidated Health Economic Evaluation Reporting Standards (CHEERS)—Explanation and Elaboration
Preferred Reporting Items for Systematic Reviews and Meta-Analyses
| Unique citing works | 254 |
|---|---|
| Citations per year | 25,4 |
| Citation span | 2016 - 2026 (11) |
| Citation velocity | current |
| Highly cited | Yes |
| Citation types | Neutral: 244 |